LifeStance Health Group, Inc. (NASDAQ:LFST) Stock Has Average Price Target of $12.88 According to Brokerages

Key Points

• Analysts maintain a moderately bullish outlook: LifeStance Health Group has a consensus “Moderate Buy” rating, with six buys, one strong buy, and four holds. The average 12-month price target is $12.88.
• Recent results exceeded expectations: The company reported quarterly EPS of $0.06 versus estimates of $0.03, while revenue rose 26.1% year over year to $435.35 million.
• Insiders have been substantial sellers: Company insiders sold 13.78 million shares worth approximately $146.4 million over the past three months, while institutional investors own 85.5% of the stock.

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven research firms that are covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $12.88.

Several equities research analysts recently commented on the stock. Barclays boosted their price objective on shares of LifeStance Health Group from $13.00 to $15.00 and gave the stock an "overweight" rating in a research note on Thursday, September 10th. Zacks Research lowered shares of LifeStance Health Group from a "strong-buy" rating to a "hold" rating in a report on Monday, July 13th. Wall Street Zen cut LifeStance Health Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 5th. JPMorgan Chase & Co. raised their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the company a "neutral" rating in a research report on Friday, August 14th. Finally, BTIG Research lifted their price objective on LifeStance Health Group from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, August 19th.

Insider Transactions at LifeStance Health Group

In other news, CTO Vukasin Paunovich sold 42,067 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $12.87, for a total value of $541,402.29. Following the sale, the chief technology officer directly owned 205,379 shares of the company's stock, valued at approximately $2,643,227.73. This represents a 17.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Lisa Miller sold 47,912 shares of the firm's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the transaction, the chief operating officer owned 281,289 shares of the company's stock, valued at $3,051,985.65. The trade was a 14.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 13,777,580 shares of company stock valued at $146,433,781. Insiders own 3.50% of the company's stock.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of LFST. Assetmark Inc. grew its holdings in LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company's stock valued at $60,000 after buying an additional 1,367 shares in the last quarter. Allworth Financial LP increased its holdings in shares of LifeStance Health Group by 7.7% in the 2nd quarter. Allworth Financial LP now owns 26,532 shares of the company's stock worth $284,000 after buying an additional 1,889 shares during the last quarter. Diversified Trust Co increased its stake in LifeStance Health Group by 14.8% during the first quarter. Diversified Trust Co now owns 21,532 shares of the company's stock worth $137,000 after acquiring an additional 2,770 shares during the last quarter. IFP Advisors Inc increased its position in shares of LifeStance Health Group by 316.5% during the 2nd quarter. IFP Advisors Inc now owns 3,694 shares of the company's stock valued at $40,000 after purchasing an additional 2,807 shares during the last quarter. Finally, KBC Group NV bought a new stake in LifeStance Health Group in the first quarter worth $29,000. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Price Performance

LFST opened at $11.83 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 91.01 and a beta of 1.24. The stock has a fifty day simple moving average of $12.07 and a two-hundred day simple moving average of $9.58. LifeStance Health Group has a 12-month low of $4.77 and a 12-month high of $13.56.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.03. The firm had revenue of $435.35 million for the quarter, compared to analysts' expectations of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The company's quarterly revenue was up 26.1% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.01) EPS. Research analysts predict that LifeStance Health Group will post 0.16 earnings per share for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.